4.7 Review

Living Therapeutics: The Next Frontier of Precision Medicine

期刊

ACS SYNTHETIC BIOLOGY
卷 9, 期 12, 页码 3184-3201

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acssynbio.0c00444

关键词

microbiota; microbial engineering; living therapeutics; synthetic biology

向作者/读者索取更多资源

Modern medicine has long studied the mechanism and impact of pathogenic microbes on human hosts, but has only recently shifted attention toward the complex and vital roles that commensal and probiotic microbes play in both health and dysbiosis. Fueled by an enhanced appreciation of the human-microbe holobiont, the past decade has yielded countless insights and established many new avenues of investigation in this area. In this review, we discuss advances, limitations, and emerging frontiers for microbes as agents of health maintenance, disease prevention, and cure. We highlight the flexibility of microbial therapeutics across disease states, with special consideration for the rational engineering of microbes toward precision medicine outcomes. As the field advances, we anticipate that tools of synthetic biology will be increasingly employed to engineer functional living therapeutics with the potential to address longstanding limitations of traditional drugs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Short FcRn-Binding Peptides Enable Salvage and Transcytosis of scFv Antibody Fragments

Vince W. Kelly, Shannon J. Sirk

Summary: In research on therapeutic antibodies, modifying antibody fragments with short FcRn-binding peptide domains enhances their binding with FcRn to achieve recycling and transmembrane transcytosis. Further studies show that rational, single amino acid mutations to the peptide sequence significantly impact the receptor-mediated function and the underlying structural basis is investigated using computational modeling. Finally, the identification of a short peptide from human serum albumin enables FcRn-mediated function when grafted onto a single-chain variable fragment (scFv) scaffold.

ACS CHEMICAL BIOLOGY (2022)

暂无数据